⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL984049 | 0.63 | — | — | |
| SCHEMBL2037829 | 0.59 | — | — | |
| SCHEMBL2039545 | 0.59 | — | — | |
| SCHEMBL4549614 | 0.59 | — | — | |
| SCHEMBL13383265 | 0.59 | — | — | |
| SCHEMBL63549 | 0.59 | — | — | |
| SCHEMBL902634 | 0.59 | — | — | |
| SCHEMBL34473396 | 0.59 | — | — | |
| SCHEMBL190032 | 0.59 | — | — | |
| SCHEMBL1005610 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102428087-B | Imidazopyrazines for use as kinase inhibitors | CT NAC DE INVESTIGACIONES ONCOLOGICAS | 2015-06-17 | — | — | CN | disclosed |
| CN-102428087-A | Imidazopyrazines for use as kinase inhibitors | CT NAC DE INVESTIGACIONES ONCO | 2012-04-25 | — | — | CN | disclosed |